A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Allergan

Status: Completed

Conditions: Ocular Hypertension; Glaucoma, Open-Angle

Treatments: Other: Standard of Care

Study type: Observational

Funder types: Industry

Identifiers

NCT01628614

MAF/AGN/OPH/GLA/028

AGN-EPI-2010-01 (Other Identifier)

Details and patient eligibility

About

This is an observational study and will evaluate IOP reduction in newly diagnosed patients with POAG or OHT. All care (including treatment and diagnostic procedures) provided is at the discretion of the participating physicians according to their clinical judgment and the local standard of medical care.

Enrollment: 4,812 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Newly diagnosed with primary open angle glaucoma or ocular hypertension

Exclusion criteria

• None

Trial design

4,812 participants in 1 patient group

POAG or OHT

Description:

Patients with POAG or OHT. All care (including treatment and diagnostic procedures) provided is at the discretion of the participating physicians according to their clinical judgment and the local standard of medical care.

Treatment:

Other: Standard of Care